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The National Poliomyelitis Surveillance Program was announced on 
April 28, 195$ 3 and inaugurated on May 1 with the PSU Report No, 1, For 
more than a year discussions had taken place within the Communicable Disease 
Center and with State Epidemiologists and others concerned over the 
desirability of developing such a program. The occurrence of more than the 
expected number of cases of poliomyelitis in some children vaccinated with 
some of the products of one manufacturer lead to an acceleration of these 
plans. The response from the State Health Departments and participating 
laboratories has been prompt and thorough, A two way flow of information 
through the PSU Reports has been established so that all technical persons 
needing the report have been kept currently informed as to the status of 
the changing and often misunderstood situation,.
Now the immediate epidemiologic emergency seems to have passed, Ik 
is time for a careful reappraisal of the objectives of the National 
Poliomyelitis Surveillance Program, Future procedures both for field 
epidemiology and for laboratory confirmation should be planned in relation ̂  
to future needs and anticipated future problems. The experience of the 
two months dictates a number of changes. The routine aspects of the surve. 
lance procedures should be cut back to a basic minimum, A unique opportun 
for additional studies of the effectiveness of the vaccine is afforded by ̂  
the current short supply and its restriction for a limited period of time 
1st and 2nd grade children. The amended minimum requirements promulgated 
by the National Institutes of Health for the production of poliomyelitis 
vaccine have been directed primarily toward increasing the safety of the 
product. These increases in safety testing should serve effectively to^ 
eliminate the possibility of future incidents. The fact that 
toward insuring safety of the vaccine have been taken further 
the poliomyelitis surveillance program should be revised and 
in order that the effiacy of the vaccine may be further evaluation,
I, Statement of Objectiveness of Poliomyelitis Surveillance
The Objectives of the Poliomyelitis Surveillance Program can be ̂ 
stated as follows: (See discussion of Changing Concepts of Poli°
Surveillance in appendix)
1, To carry on continuing studies of the incidence of poliomyelitis 
and polio-like infections in the nation to aid in the most 
effective application of control procedures,
2, To undertake studies of the effectiveness of the poliomyelitis 




II, Routine Poliomyelitis Surveillance
should
;inatiorlTo attain these objectives a continuing routine surveillance be maintained in each State and Territory, A history of polio va 
should be obtained in every case of reported poliomyelitis. If vaC '̂Liig an<5 
was given, the following data should be collected2 date of onset, ^  
site of inoculation, manufacturer of vaccine, lot number, and site 0 ̂  
paralysis. If two inoculations were given, full data on both should 
collected
If the interval from vaccination to onset is 30 days or less, the 
^stion of the safety of the particular lot of vaccine used must be 
c°nsidered, especially if there, is correlation between site of inoculation 
first paralysis. It is expected that there will be cases in vaccinated 
tildren under 30 days as a result of ineffectiveness of vaccine in some 
children.
In any event the health officer should survey immediately:
1. The extent to which the same lot of vaccine has been vised,
2. The occurence of additional cases among such vaccinated 
persons, or among parents and siblings of vaccinated children,
3* Incidence of minor illness following vaccinations.
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* Specimens should be submitted, including stools from cases, and
other vaccinated children when epidemiological investigation warrants, 
specimens for complement-fixation tests may also be useful for 
Resting recent infection.
If the interval from inoculation to onset is more than 30 days, the 
efi63^ 011 t îe e^ :*acy’ the particular lot of vaccine must be considered, 
specially if a group of such cases is reported. Each situation will 
4Uitb careful epidemiological appraisal comparing the general incidence 
.Paralytic polio in the community with the incidence rate among vaccinated 
Specimens for laboratory examination should be submitted for 
^so-!-a'biori an<̂  typing. It is conceivable that vaccines may vary in 
lab °e^ree °£ Pype specific immunity conferred. Also careful clinical and 
oratory appraisal is essential to establish diagnosis.
&te '̂ ie Revised Procedures for reporting to PSU in Atlanta
, ^commended to become effective immediately:C t
Telegraphis report giving minimum essential data for each case 
°f poliomyelitis in a vaccinated person with interval 30 days or 
less -vaccination to onset. PSU case form to be sent by air 
Wail, when data are complete.
PSU case form by air mail for each case in a vaccinated 
Person when interval between inoculation and onset is over 30 days.
■that narrative accounts by air mail of any unusual situations
"fcy relate to possible safety or effectiveness of vaccine.
sp0l> Narrative reports on the occurrence of outbreaks or significant 
,c cases of polio-like illnesses such as encephalitis, Coxsackie 
-Sections, leptospirosis, etc. These reports should also be sent 
Ui-taneously to NOVS.
R e p osed Vaccine Studies for 1955
To
thr
attain the second objective of the National Polio Surveillance 
several tyoes oi study can be visualized. These may be grouped 
ee broad categories:
• General Age Distribution Analyses 
Specific Age Group Investigations 
Epidemic Studies
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The first of these, General Age Distribution Analyses, are relatively 
simple extensions of the Routine Surveillance procedures. Data on the age 
incidence of polio can be accumulated for comparison with the abundant 
data of previous years. Since immunization this year will probably be 
limited largely to 1st and 2nd grade children or at least to 5“ $ year 
olds, a reduction in incidence in these immunized age groups should become 
clearly apparent and serve as a rough measure of the effectiveness of the 
vaccine. This type of study should not be considered as a controlled 
study but rather as an organized collection of descriptive data that is 
applicable on a broad national scale. It is hoped that most states will 
elect to participate with the Polio Surveillance Unit in this phase of 
the study.
The procedures to be followed by participating states will be the 
submission of a weekly report to PSU on each Friday of all new verified 
cases of polio reported in the state. A special form, copy attached, 
will be available on request. Cases are to be listed only when they have 
been accepted by the State Polio Reporting Officer with paralytic status, 
date of onset and age established to his satisfaction. The number of 
such cases reported to FSU each week will not correspond with the current 
provisional incidence data reported each week to NOVS because some delay 
will be required to establish the facts. Indeed the cumulative totals 
reported to PSU will tend to be lower because some cases reported to NOVS 
will be later withdrawn as not confirmed polio.
This type of study has been purposefully planned on assimple a 
basis as possible. No data are requested on laboratory examination, 
history of vaccination or extent of paralysis. Such details should be 
reserved for the special investigations and epidemic studies.
It is proposed that these General-Age Distribution Analyses cover 
the period from April 12 to October 31, inclusive. Many case reo-orde 
have already been reported to PSU. A listing of these cases by date of 
onset from April 12 to June 30 on the new form will be submitted to any 
participating state on request as a starting point for checking records 
and making listings complete. Subsequent reports from States should be 
prepared in duplicate with one copy being retained in the state for f'ar 
reference.
As reports accumulate at PSU they will be consolidated and publisNe<* 
at regular intervals in the PSU reports as nearly weekly as possible*
The Special Age Group Investigations are visualized as more 
research studies, that certain states may develop in relation to parti 
opportunities or special local circumstances. The expected limitation 
vaccination to a narrow age span will permit special studies which wi-1̂ - ^ 
be comparable in some respects to the observed control studies of "the 
Vaccine Evaluation. Either a whole state or any specified area within 
state might be included. The study areas of the 195b evaluation, b° 
placebo control and observed control groups, will be most interesting 
follow.
In those states where it is possible to make reasonable approxii® 
tions of the nuriber of children in specified age groups that have re 
vaccinations, attack rates may be determined for vaccinated children
h —
Vaccinated children of the came age or* of reasonably comparable age 
S^oups immediately younger and older than the vaccinated group* In 
^tates where groups that received one and two doses this year can be 
'tefined, and in areas where 195>U evaluations were carried out and where 
°oster inoculations were given this year, even more detailed investigations 
Can "be undertaken*
The basic procedures necessary for such studies are a..field invests 
Sat ion by a trained worker to verify the clinical data, to determine the 
eXact dates of onset, history of vaccination and dates of inoculation, 
Viufacturer and lot number, and to collect specimens for laboratory 
confirmation of diagnosis. A 50 to 70 day muscle grading by a qualified 
Physical therapist along with isolation and typing of virus would add 
Materially to the accuracy and value of the study.
While the detailed plans for these special studies must be developed 
^  relation to the local circumstances and opportunities, and while 
™ a r y  responsibility for directing the studies should remain local, the 
t will make a maximum effort to provide collaborative support upon Request.
Epidemic Studies will be of special importance this year. In some
epidemic situations local authorities will choose to avoid use of polio 
0£C+ ̂ne* ^ere it should be possible to obtain the most accurate evaluation 
e h"16 effectiveness of the vaccine among children inoculated before the 
at i r,1̂ c began. In other areas authorities may well continue vaccination 
-Least in selected age groups, if supplies of vaccine are available, 
and^ ° u s  field epidemiological studies supported by clinical, laboratory 
ev iPhysical therapist examinations will be most important not only to 
spirt a^6 "khe effectiveness of vaccine as a procedure for the control of 
demies but also to determine the extent of the possible provoking
It is believed that the services of CDC may be particularly 
aPplicable in such epidemic situations during the present summer* --LI 
^ignments of Epidemic Intelligence Service Officers will be contingent 
aP°n their availability for such epidemic studies both within the State 
bbeir assignment and elsewhere.
IV. §®£yices Available from CDC
his ^be following types of services are being organized by the Communicable 
Wi-(.̂a'5e Center and will be available to the States on request commensurate 
Maintaining a national balance in the program:
Forms
a. Polio Surveillance Form
A case investigation form for field use for routine 
surveillance or for special studies or epidemics
b« Age Distribution Analysis Form
A simple roster for weekly reports to PSU by States 
participating in this phase of surveillance
C» Laboratory Specimen Forms
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Two forms are available, one for submission of specimens 
to the laboratory and the other for the laboratory reports# 
The upper half of both forms is identical and contains 
identifying data and description of the specimens submitte » 
The lower half of the first form is detachable and will be 
returned upon request to the sender as acknowledgement of 
receipt of the specimen. The lower half of the second 
form will be forethe results of the laboratory tests.
2. Consultation and Epidemic Aid.
The full resources of Epidemiology Branch, CDC are alerted for 
first priority duty on Polio Surveillance during the present summer. 
Epidemic Intelligence Cfirvice Officers, (physicians, t rses and 
statisticians) will be available for epidemic aid and for assistance 
in locally developed and directed special studies.
3. Physical Therapy
Arrangements for physical therapists to participate in special 
studies should be worked out directly by the states. Where 
this is not achieved, CDC stands ready to assist in arranging 
for PT services.
U. Laboratory Diagnosis
Funds have been made available in Hay and June 1955 through the 
NIH to several laboratories to support laboratory references' 
diagnosis services in Polio Surveillance, and beginning in 
July 1955 funds will become available through CDC. Further 
information regarding these laboratory services should be 
obtained through Dr. Ralph Hogan, Chief, Laboratory Branch,Cffl
5. Reports
The periodic PSU Reports will continue on the present FOR 
OFFICIAL USE ONLY basis to avoid possible misinterpretations 
of the incomplete and often quite fragmentary data that will 15 
included. In addition to publishing data on routine surveill311 
and general age distribution analyses, progress reports of 
special studies, epidemic situations, or interesting laboratory 
findings will be included when submitted by responsible inves 
gators. These alse will be limited to OFFICIAL USE ONLY in ora 
to encourage the maximum interchange of information among 
technical persons participating in the Surveillance Program* 
However, it is expected that consolidated scientific reports 
fully evaluated data will be given at appropriate scientific 
meetings.
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Appendix I
^liPging Concepts of Poliomyelitis Surveillance
. As originally conceived. Poliomyelitis Surveillance was patterned 
ber other CDC Surveillance Programs such as those for malaria, smallpox 
other communicable diseases of national importance. Experience has 
town that one of the primary problems with these diseases was faulty 
lajpiosis leading to erroneous reporting. It was anticipated that this 
Problem would also be encountered in Poliomyelitis Surveillance as an 
ĉ easinS number of children became immunized,, Furthermore it was expected 
 ̂at a substantial number of the children in the country would be immunized 
Wo t**16 polio season and the major problem during the coming season
’tLd be the occurrence of outbreaks and sporadic cases of a variety of 
n ections that simulate polio but that actually were other diseases. If 
correctly diagnosed such cases might lead to considerable worry, if not 
ĵ/imunity alaritl and if frequent in occurence would lead to discrediting of 
g ® vaccine erroneously. It was also recognized that the contemplated 
th Ve^ lance Program would provide useful data on any defects either in 
to ,1ê icacy or safety of specific lots of vaccine, although this was felt 
be a rather remote possibility,
Stjt ?ne °- hhe assumptions that was made at the beginning of the 
>inVe^'^ance Program was that, if associated cases were due to live
cerbaan lots of the vaccine, then the cases developing would 
jjjj’t from inoculation of virus into the peripheral nerves, and systemic 
jjetiecb^°n would be unlikely. Such cases would probably not be infectious. 
holrt6 SbecaaE emphasis was placed on examining stool specimens from house- 
all Conbacts with the concept that the virus would be found rajfly if at. 
among contacts of such "inoculation” cases. ■
fj. Experience showed this as sumption to be quite wrong. Stool specimens 
vjj, household contacts of inoculated cases yielded Type 1 poliomyelitis 
vaccs °n num.es-ous occasions. Furthermore the virus was isolated from' 
s t a t e d  children who had only mild febrile illnesses, sore throats, 
spte?1 uPsetsj °r no symptoms at all. These individuals apparently 
hheir infection to parents and siblings. Thus the laboratory 
Caselna^ on sbo°l specimens from household contacts of vaccinated 
sPont ^aS not Proved useful in distinguishing inoculation cases from 
to i ane°us or coincidental cases. This formerly recommended procedure 
°nger needs to be followed.
itfe bhe other hand the occurence of numerous mild or inapparent 
^Pld lanS -®-°hl°w ing vaccination points to new procedures for the most 
appe -̂ ield detection of unsafe lots of vaccine in the future should any
Whenever minor illnesses or febrile reactions occur with increased 
VaCc êricy following vaccination, stool specimens from a group of these 
to*, r^hed children should be collected and submitted to a virus laboratory 
Stnâ lgh priority attention. The isolation of polio virus from even a 
lot blUnher of such cases would be strong presumptive evidence of an unsafe 
The c , vaccine if these were few or no other cases reported in the community, 
the £?^ection of such laboratory evidence might be initiated well before 
ftofrg associated paralytic cases were reported. Also whenever one or 
C&Ses °f poliomyelitis occur in vaccinated persons under circumstances 
Suggest the possibility of inoculation poliomyelitis, the most rapid
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method to check the possibility would be to collect the specimens from a 
number of children who had received the same lot of vaccine and submit 
them to a laboratory. The finding of several carriers would suggest the 
possibility of unsafe lot of vaccine, but it might not be conclusive*
At the initiation of the Surveillance Program as mentioned previously* 
it was anticipated that a large proportion of the children in the country 
would be inoculated by August 1, It was expected that only a moderate 
number of cases of polio would be reported and that most of these would 
fail to be confirmed by laboratory study. On these assumptions each State 
was requested to submit "minimum essential information" on all reported 
cases and to seek laboratory confirmation whenever possible,
.Now it is apparent that the available supplies of vaccine may be so 
limited that few children outside the first and second grades will receive 
immunizations before the polio season is well underway. Therefore the 
incidence of polio this year may be such that daily individual reports on 
all cases to the PSU could become a severe burden. Revision of procedures 
is clearly indicated.
Finally the situation is now developing in many ways similar to 1 9 &  
at the time when the Vaccine Evaluation Program under Dr, T. Francis, Jry  
was initiated, kfost 1st and 2nd grade children have received one dose of 
vaccine and many have been given or will receive a second dose in the nea 
future. Also children who participated in the 1951l- evaluation have re^e® D 
booster doses. Large and well identified populations of vaccinated child 
are available for observation. A unique opportunity is thus afforded to 
evaluate on a comprehensive and practical scale, the effectiveness of the 
Polio vaccine as used in 1955,‘ The procedures already developed for 
Poliomyelitis Surveillance can be readily adapted to certain broad types 
of study. Several states have indicated their interest in conducting 
detailed studies.
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1. Name of Patient 2. Sex 3. Age
Date of 





7. Address 8. School 9. Grade
Date Onset Site of First
10. Date Patient First Felt Unwell____________________Paralysis____________________________  Paralysis___
11. Description of Illness: 12. Extent of Paralysis:
Yes No
Fever Sore Throat Right Arm □ Right Leg □
Headache Vomiting
□ □Stiff Neck Diarrhea Left Arm Left Leg
Stiff Back Constipation
□ □Back Pain Muscular Pain Bulbar Trunk
Spinal Fluid: Yes No Cells Protein 14. Gamma Globulin Administered: Yes___ No_ Date
15- Muscle Evaluation: Yes___ No___ Date Score By Whom_





19. Poliomyelitis Vaccination: Yes No
Infection: (1) Date Site
(2) Date Site
(3) Date Site














Specimen (.V) Date Collected _ 
Specimen (.2) Date Collected 
Specimen (3) Date Collected
^ . s .-----<c---
v. vivv-t isv v-t. -a.
VAb. Sent to_ 
tab. Sent to 
_Lab. Sent to




Acute Spec.(l)Date Collected_________________ Lab. Sent to____________________________________________________________________ Date Sent
Conval.Spec. (2)Date Collected_________________ Lab. Sent to____________________________________________________________________ Date Sent
Conval.Spec. (3)Date Collected_________________ Lab. Sent to____________________________________________________________________ Date Sent
3. Family Contacts;
Name Age Sex
Vaccinated Illness* Date Stool 
Collected
Date Sent 
to Lab. Laboratory Sent toYes No Yes No
•(Defined as febrile illness at any time beginning two weeks prior to date patient named in Item 1 first felt unwell)
Name(s) of Informant(s) Relationship to Patient
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1. All states participating in the Age Distribution Analysis of the 
1955 Poliomyelitis Vaccine Study are requested to submit information 
weekly on all cases of poliomyelitis occurring in their state. Cases 
should be listed as soon as they have been accepted by the State 
Poliomyelitis Reporting Officer and their status (paralytic or non- 
paralytic) has been determined.
2. All cases should be listed regardless of vaccination history. (A 
Poliomyelitis Surveillance Case Form should also be submitted on 
all cases vaccinated in 1955 as part of the Routine Surveillance 
Program.)
3. The Age Distribution Analysis Form should be completed in duplicate and 
the original copy airmailed each Friday to the Poliomyelitis Surveillance 
Unit, Communicable Disease Center, 50 Seventh Street, N.E., Atlanta 23, 
Georgia. The carbon copy should be retained by the state for reference.
4. Space is provided at the bottom of the form for revisions of previously 
listed cases. Such cases should be listed in their revised form with 
the date, sheet number and line number of the original listing indicated.
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^LIC HEALTH SERVICE COMMUNICABLE DISEASE CENTER
POLIOMYELITIS SURVEILLANCE UNIT
COLLECTION OF SPECIMENS FOR POLIOMYELITIS DIAGNOSIS
hav ̂ ecommenc3ations on the selection of individuals for laboratory study 
Ve been outlined in a separate communication.
0£ following generally accepted methods are recommended for collection 
at a . at°ry specimens. Instructions from individual laboratories rnay be 
^  variance with these recommendations, particularly if designed for special 
lesj and should be followed when available.
Shipments should be timed so that laboratory specimens arrive on a work- 
Yj and not on weekends or holidays, whenever possible.
FORT'S
Two
0 laboratory forms will be used for poliomyelitis reference diagnosis. 
:cî -̂ . cjjien Shipment Form is to be filled out by the field investigator and 
^ t h  the specimen to the diagnostic laboratory. A section of this form 
of s .delached and remitted to the field investigator-to confirm receipt 
, Pecimen by the laboratory. The remainder of the form will be retained 
e laboratory.
labor~T~~~~-2 ̂ apont Form will be filled out in quadruplicate by the 
be ,.al°ry when laboratory diagnosis has been completed. Four copies will 
sPeciS',ril3Û e^ as l°ll°ws: Copy 1* Mail to the field investigator submitting 
to Copy 2; Mail to the ~PSU$ $0 Seventh Street, Atlanta; Copy 3 : Mail
e State Health Department; Copy U: Retained by Laboratory.
STOOL SPECIMENS
£oUect‘ Obtain a stool specimen as early as possible after onset of 
sterfiS* • ^Se a receplacle which contains no disinfectant. Transfer to a 
UnQbta^ ^ar> ointment box, or waxed container. If a regular stool is 
(do n0+nablej one °f hhe following methods can be used: 1) tap water enema 
ati0n, soapsuds); 2) specimen collected on a glove by rectal examin-
swab s), rectal swab which must contain visible fecal material. Rectal 
c°htas he suspended immediately in a screw-cap liquid tight bottle 
^ ing 1 , 0  cc of sterile water.
sPsc5TnfeCOn^ sf°°i specimen should be collected 1 to 3 days after the first 
n has been obtained.
§£<xrage. R̂efrigerate in deep freeze or freezing compartment of refrigerator.
a specimen will be in transit less than 2U hours it can be 
pi, ^fhout refrigeration. A specimen which will be in transit more 
hours should be mailed in a refrigerated container as follows: 
h o ^  Cltten (s) should be packed in dry ice (solid carbon dioxide),in a card- 
> t a : h S ta:Lner or insulated paper bag and this packed inside a larger- 
Ûst ^  with insulation between the two containers. Shredded paper, saw- 
^SeabT50̂  Savings or other available material may bd used for insulation.
+ Corimercial shipping boxes are also available'. Note: Glass
*See r h-ype containers are too fragile for mailing and should be avoided. 
°otnote on page 2.
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BLOOD SPECIMENS
Collection; Two specimens must be obtained on every patient studied, 
serologically. The first specimen should be obtained on the first day of 
observation, the second specimen two to four weeks later.
Obtain 10 cc of blood in a sterile dry syringe and transfer whole blood 
to a sterile tube, ihe tube should be closed with a paraffin-dipped cork 
stopper and secured with tape. Do not use anticoagulants or preservatives 
in the test tube. Commercially prepared bleeding tubes in vacuum contaih®r 
may be used to draw blood conveniently when the number of patients are lar£e 
or in the field where syringes and needles are not readily available.
Storage; Specimens to be shipped within 2lt hours of collection can be sent 
as whole blood. Such specimens may be kept over night in an ordinary 
refrigerator. Specimens to be stored for longer periods must be processed 
as follows; 1) allow several hours after collection for formation of blood 
clot; 2) centrifuge until clot is packed firmly (usually 1 5  minutes in an 
ordinary laboratory centrifuge at about 2000 RPM) and pour off serum; 3) 
store serum in an ordinary refrigerator*
Shipment; Whole clotted blood or serum specimens may be shipped without 
refrigeration but should be carefully packed to prevent breakage. Ship 
regular mail special delivery to laboratory within 100 riles, air mail- 
special delivery to laboratories over 100 miles distant.
POST-MORTEM SPECIMENS
Collection; At the time of autopsy obtain under sterile precations the 
following samples if possible; 1) a section \ inch thick from medulla* P°n * 
mid-brain, and cervical and lumbar enlargement of the spinal cord; 2) a 
specimen of tonsillar tissue; and 3) a 3-inch segment of the descending 
colon tied off at both ends. (The last is particularly important if no 
ante-mortem stool specimens have been obtained.) Wherever possible, hxs 
logic examination of the Central Nervous System for evidence of polionye 
should be requested £rom the local pathologist.
Blood specimens, if not obtained ante-mortem, can be obtained post­
mortem and handled as suggested above.
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Storage; Specimens may be transferred to sterile containers or suspended 
sterile solution of half-and-half glycerol and saline. Glycerinized spe^  
mens may be stored in an ordinary refrigerator. Untreated specimens she 
be kept in a deep freeze.
Shipment;Specimens must be carefully packaged to avoid breakage. If 
suspended in glycerol-saline, refrigeration Is not necessary. 0therwise>  ̂
specimens should be packed in dry ice in a cardboard container car 
paper bag, and then packed inside a larger container with insulation be 
the two containers. Shredded paper, sawdust, wood shavings, or other „ 
available material may be used for insulation,, Reusable commerical ship 
boxes are also available.^ All specimens should be dispatched to the 
laboratory with the least possible delay,,
* Boxes of this type costing about '317.50 may be obtained from; The Ha 
Corporation, 383k S, Four-Mile Run Drive, Arlington Virginia. Similar ^  
containers produced by other manufacturers would be equally useful. 
boxes will be returned to the sender promptly for subsequent shipments.
